Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Precision Biosciences Inc
(NQ:
DTIL
)
10.88
+0.33 (+3.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Precision Biosciences Inc
< Previous
1
2
3
4
5
Next >
Precision BioSciences to Host In Vivo Gene Editing R&D Event on September 9, 2021
August 25, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reports Second Quarter 2021 Financial Results and Provides Business Update
August 12, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report Second Quarter 2021 Financial Results on August 12, 2021
August 05, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Doses First Patient in Phase 1 Allogeneic CAR T Clinical Trial of PBCAR19B Immune Evading Stealth Cell for Relapsed/Refractory Non-Hodgkin Lymphoma
July 01, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma
June 28, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reports Progress on Two Strategies Designed to Optimize Durability of Allogeneic CAR T Therapy in R/R Non-Hodgkin Lymphoma
June 04, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo
June 01, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Appoints Alex Kelly as Chief Financial Officer
May 27, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in the Jefferies Virtual Healthcare Conference
May 26, 2021
From
Precision BioSciences Inc.
Via
Business Wire
Precision BioSciences to Present Data from its First Generation CD19 Allogeneic CAR T Program in Relapsed/Refractory Non-Hodgkin Lymphoma at the 2021 American Society of Clinical Oncology Meeting
May 19, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reports First Quarter and 2021 Financial Results and Provides Business Update
May 13, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
New Preclinical Data Presented at the 2021 American Society of Genetic & Cell Therapy Annual Meeting Highlights Precision BioSciences’ ARCUS In Vivo Genome Editing
May 11, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report First Quarter 2021 Financial Results on May 13, 2021
May 06, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Paper Presentation at the Association for Research in Vision and Ophthalmology 2021 Annual Meeting
May 03, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Poster Presentation at the Upcoming American Society of Gene & Cell Therapy Annual Meeting
April 27, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Appoints Renowned Hematologist Alan List, M.D. as Chief Medical Officer
April 15, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reacquires Global Rights to its Allogeneic CAR T Programs
April 15, 2021
From
Precision BioSciences Inc.
Via
Business Wire
Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of Directors
April 12, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in the Truist Securities 2021 Life Sciences Virtual Series
April 09, 2021
From
Precision BioSciences Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.